儿童的心脏病:炎症综合征
Craig Barstow1, Ryan Flanagan2
1FirstHealth of the Carolinas, Pinehurst, NC.
FP essentials
|February 17, 2025
概括
川崎病和MIS-C是影响儿童的炎症状况,潜在的心脏并发症. 肌心炎与COVID-19和疫苗有关,需要进一步研究.
科学领域:
- 儿科风湿病学 儿科风湿病学
- 传染性疾病 传染性疾病
- 心脏病学 心脏病学
背景情况:
- 川崎病是一种急性血管炎,主要发生在5岁以下的儿童身上,心脏并发症如心肌炎和冠状动脉扩张是主要问题.
- 儿童多系统炎症综合征 (MIS-C) 是一种与COVID-19相关的过度炎症状况,与Kawasaki疾病有共同特征,经常导致心脏功能障碍.
- 心肌炎,心肌的炎症,有多种原因,与COVID-19感染和mRNA COVID-19疫苗有关,尽管其重要性正在调查中.
研究的目的:
- 为了区分川崎病和MIS-C.
- 讨论与COVID-19和疫苗有关的心肌炎.
- 突出目前关于这些条件的研究和辩论.
主要方法:
- 文献综述和临床特征的综合.
- 诊断标准和治疗方案的比较.
- 对流行病学数据和研究结果的分析.
主要成果:
- 川崎病和MIS-C存在重叠的症状,但具有不同的炎症概况和管理策略.
- 肌心炎是COVID-19感染的已知的并发症,在mRNACOVID-19疫苗接种后已经观察到.
- 疫苗相关心肌炎的确切发病率和长期临床影响需要进一步阐明.
结论:
- 早期识别和适当治疗Kawasaki病和MIS-C对于预防心脏后果至关重要.
- 持续的研究对于理解COVID-19,疫苗和儿科患者心肌炎之间的复杂关系至关重要.
- 区分这些炎症综合征和了解心肌炎的关联是未来儿科研究和临床实践的关键领域.
相关概念视频
Inflammation
52.3K
Overview
52.3K
Ischemic Heart Disease: Overview
1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Psychoneuroimmunology: Cardiovascular Disease
25
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
25
Pulmonary Hypertension: Classification and Pathogenesis
147
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
147
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K


